According to a recent market study published by Growth Market Reports titled, "Global Naringin & Neohesperidin Market by Type, End-use Industry, and Regions: Size, Share, Trends and Opportunity Analysis, 2018-2028", the market was valued at USD 1,388.9 Million in 2020 and is expected to grow at a moderate growth rate of 5.3% by the year 2028. The global Naringin & Neohesperidin market is anticipated to grow significantly during the forecast period. Huyou (Citrus changshanensis) is rich in naringin and neohesperidin.

Naringin and neohesperidin from Huyou act as potential hypoglycaemic agents by regulating glucose metabolism. The supplements of naringin are used for the treatment of obesity, diabetes, hypertension, and metabolic syndrome. The U.S. Food and Drug Administration (FDA) Standards of Identity for frozen concentrated orange juice allow orange juice from C. sinensis to contain up to 10% juice from tangerine or tangerine hybrids and up to 5% juice from sour orange.

Request a free sample copy @

Global Naringin & Neohesperidin Market has been segmented based on type, end-use industry, and regions. Based on type, the global Naringin & Neohesperidin market is segmented into naringin & neohesperidin. The naringin segment is further categorized into food grade, pharma grade, and others. The neohesperidin segment is further categorized into food grade, pharma grade, and others. Based on end-use industry, the global Naringin & Neohesperidin market is segmented into food & feed additives, pharma & healthcare, and cosmetics and personal care.

Based on regions, the global Naringin & Neohesperidin market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. 
The naringin segment is projected to hold a significant Naringin & Neohesperidin market share during the forecast period. Naringin found in oregano, cherries, tomatoes, grapefruit, pummelo, grapefruit juice, and other grapefruit hybrids are significant sources of naringin and are mostly consumed foods. Naringin is a flavonoid, which gives grapefruit a bitter taste.

Naringin is mainly incorporated as a flavoring and/or bitter agent. It is used in syrups, carbonated drinks, sauces, sweets, and to produce confectionery and bakery products. In some formulations of bitter drinks, it is an ideal substitute for quinine. Food products containing naringin are recommended as a probable supplementation to the existing treatments for various disorders and to maintain health. 
The spread of COVID-19 has had a positive impact on the Naringin & Neohesperidin market players on many fronts and outside factors.

The COVID-19 pandemic is causing economic hardships for businesses, consumers, and communities across the world.
The production of naringin and neohesperidin increased during the pandemic, as cedrat (Citrus medica) and ginger (Zingiber officinale) provide herbal solution for throat and nasal cleaning. Import and export of naringin and neohesperidin were not affected during the pandemic. Thus, driving the market during the pandemic. Demand for naringin and neohesperidin increased during the pandemic, due to their high demand in the pharmaceutical industry for nasal and throat cleansing.

Governments imposed various restrictions on trade and commerce, which restrained various sectors. Naringin and neohesperidin received government approval, they are used for nasal and throat cleansing, which are symptoms related to Covid-19. Covid-19 did not hamper the naringin and neohesperidin market, as it is used in pharmaceutical & healthcare sector. Manufacturers in the market were focused on investing in R&D activities, which is drove the market during the pandemic.

Key Takeaways from the Study:

  • Naringin and naringenin supplementation proved effective for the treatment of metabolic syndrome and obesity in animal models.
  • Naringin is used for treating a range of diseases, due to its wide availability, low cost, variety of pharmacological actions, and long history of use.
  • Naringin and neohesperidin are widely used in the food industry and in animal feed industries. Two of the major identified components of the additive, namely, naringin and neohesperidin, are considered safe for use as flavorings and are currently authorized for food and animal feed uses. Naringin and neohesperidin are used in syrups, carbonated drinks, sauces, sweets, and to produce confectionery and bakery products.
  • The pharma & healthcare segment is projected to hold a considerable share of the market during the forecast period. Naringin is helpful for the treatment of metabolic syndrome, obesity, high blood pressure, and diabetes. Naringin represented a wide range of pharmaceutical activities such as anti-cancer and anti-inflammatory activities.
  • The US is projected to hold a large share of the global naringin and neohesperidin market during the forecast period, due to increasing import activities. The market in Europe is expected to grow at a rapid pace during the forecast period. Increasing awareness regarding the importance of hygiene and personal grooming is anticipated to raise product demand in the personal care and cosmetics industries, thus propelling the market.
  • Increasing government approvals for the use of naringin is expected to fuel the market in the Asia Pacific during the anticipated timeline.

Report Scope:

Report Metric


Market Value in 2020

USD 1,388.9 Million

Market Growth Rate (from 2021 to 2028)


Historical Data

2018 & 2019

Base Year


Forecast Period

2021 – 2028

Market Segments

By Type, End-use Industry, and Regions

Region Scope

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America

Key Companies Profiled

Manufacturer companies –
Maxsun Industries, Inc, Freshine Chem, NutraCap Labs, DESTILACIONES BORDAS CHINCHURRETA S.A., Otto Chemie Pvt. Ltd., INDOFINE Chemical Company, Inc., Shenzhen Drugdu Technology Co., Ltd., XI'AN RONG ZHI BIO-TECH CO.,LTD., Layn Corp., Golden Health Technology Co., Ltd., Sichuan New Hawk Biotechnology Co., Ltd., Vital Herbs, MORRE-TEC Industries, Chengdu Mansite Biotechnology Co. Ltd., HIT AGRITECH GROUP, Guangzhou HanFang Pharmaceutical Company Limited, Shaanxi Longfu Biochemical Co.Ltd, Arjuna Products, Xi'an Sanjiang Bio-Engineering Co., Ltd, Shandong Benyue Biological Technology Co., Ltd, and Plantnat
End-user companies –
SUANFARMA, Chemopharma Chemikalien- und Pharmazeutika GmbH, CLAV GmbH, Swanson, Nans Products, Shaanxi Iknow Biotechnology Co., Ltd, Merck KGaA, Sichuan YuanHongFu Technology co., Limited (YHF), Scitec Nutrition, and DarkLabs

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet your research requirements.


Target Audience:

  • Demand Side: Commercial, Residential, and Industrial End-users.
  • Regulatory Side: Concerned government authorities, commercial research & development (R&D) institutions, and other regulatory bodies.
  • Associations and Industry Bodies: International Trade Centre.